retatrutide phase 3 results 🚨 HOT OFF THE PRESS: data has arrived — and the obesity medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average Eli Lilly just announced striking

Advocacy groups including Obesity Canada have submitted cost-effectiveness reanalyses using 2024-2026 real-world data showing larger cardiovascular benefits than the original trials (Sharma et al., Canadian Medical Association Journal, 2025)

When developing our products, we work in close collaboration with leading medical professionals and nutritional experts to create premium dietary supplements that you can feel good about

Be the first to review this product.

Nutrients, 15 (12)

Products & Services Jun 24, 2026 BLOOMFIELD, Conn June 29, 2026 Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), has named Leslie Robey as general manager for the Carolinas market, effective